Diagnostic Blood Test Articles & Analysis: Older
4 articles found
“Importantly, the detection of Neu5Gc in these cancer tissues is consistent with its role as a pan-cancer biomarker and further supports the development of INOVIQ’s SubB2M-based blood tests for breast and ovarian cancers.” Findings support INOVIQ’s SubB2M diagnostics program The cell staining was independently scored by ...
SEE ALSO: Israel’s Sight Diagnostics To Supply Blood Test Analyzers To Clinics In UAE, Saudi Arabia Founded in 2010 by Yossi Pollak and Daniel Levner, Sight Diagnostics uses advanced computer-vision and machine-learning technology in the field of blood diagnostics. ...
A study of Universal Diagnostics' blood-based colorectal cancer test found it was more than 90 percent accurate, the company announced June 3. The blood test was found to detect colorectal cancer with 92 percent sensitivity and 97 percent specificity. ...
With a founding team that used to work at Mobileye, among other companies, Sight made an early bet on using machine vision to analyze blood samples and provide a full blood count comparable to existing lab tests within minutes. ...